Table 1.
Antigen | Clinical syndrome | Tumor |
---|---|---|
NMDAR (GluN1) | Anti-NMDAR encephalitis: prodromal symptoms, psychiatric, seizures, amnesia, movement disorders, catatonia, autonomic instability, coma |
Age-dependent 10–45% ovarian teratomas, infrequently carcinomas |
AMPAR | Limbic encephalitis, psychiatric symptoms | 70% (lung, breast, thymoma) |
GABAbR | Limbic encephalitis, prominent seizures | 50% lung, neuroendocrine |
LGI1 | Limbic encephalitis, 60% hyponatremia, occasional focal faciobrachial seizures prior to encephalitis |
<10% (lung, thymoma) |
CASPR2 | Encephalitis, Morvan syndrome, neuromyotonia | 0–40% thymoma |
mGluR5 | Limbic encephalitis (reported in less than 10 patients) |
Frequently, Hodgkin lymphoma |
D2R | Basal ganglia encephalitis, Sydenham chorea. | Infrequent |
DPPX | Diarrhea, encephalitis with CNS hyperexcitability: confusion, psychiatric symptoms, tremor, myoclonus, nystagmus, hyperekplexia, PERM-like symptoms, ataxia. |
No tumor association |
GABAaR | Refractory seizures, status epilepticus, or epilepsia partialis continua, stiff-person, opsoclonus |
Infrequent |
GlyR | Stiff-person, PERM, limbic encephalitis, cerebellar degeneration, optic neuritis |
Infrequent |
IgLON5 | Abnormal sleep movements and behaviors,obstructive sleep apnea, stridor, dysarthria, dysphagia, ataxia, chorea (reported in less than 10 patients) |
No tumor association |